News Sentiment

CERS sentiment intelligence

Cerus Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 3.12 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-1.3% over one week, +21.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Cerus Corporation to release Q2 2026 results on July 30

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend active 21.9% over four weeks
Fair value 68.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 39
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
Stock Titan 11
TradingKey 7
Investing.com 4
Business Wire 2
AD HOC NEWS 2
StockStory 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 22
Balance sheet 3
Analyst action 2
Regulatory and legal 1
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
scanx.trade Direct company coverage

Cerus Corporation to release Q2 2026 results on July 30

Cerus Corporation is scheduled to announce its Q2 2026 financial results on July 30, 2026, after the stock market closes. This will be followed by a conference call and webcast at 4:30 P.M. ET to discuss the financial performance, business overview, and future outlook. A replay o

Tone
Neutral 50/100
Event
Earnings
Published
16 Jul 2026 21:10
Source
scanx.trade
Stock Titan Direct company coverage

Cerus to Discuss Results and Outlook in July 30 Webcast

Cerus Corporation announced it will release its second-quarter 2026 financial results on Thursday, July 30, 2026, after the stock market closes. The company will host a conference call and webcast at 4:30 P.M. ET to discuss these results and provide a business overview and outloo

Tone
Neutral 50/100
Event
Earnings
Published
16 Jul 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026

Vivek K. Jayaraman, a CERS shareholder, has filed a Form 144 to announce the planned sale of up to 16,666 shares of CERS common stock on July 16, 2026, with an estimated market value of $52,664.56. These shares are restricted stock acquired on March 12, 2021. The filing also disc

Tone
Neutral 50/100
Event
Market update
Published
16 Jul 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman

Cerus Corporation has updated the employment terms for William Greenman following his transition to Executive Chairman, effective July 1, 2026. He will serve until May 31, 2027, with a reduced time commitment, and will receive an annual base salary of $500,000, plus an 80% target

Tone
Neutral 50/100
Event
Analyst action
Published
11 Jul 2026 01:09
Source
Stock Titan
Ad-hoc-news.de Direct company coverage

Cerus Corp faces a complex landscape as blood safety technology evolves

Cerus Corp operates in the demanding healthcare environment of blood safety systems, focusing on pathogen reduction technology. The company's success relies on the adoption of its systems by blood centers and hospitals, which face regulatory scrutiny, budget constraints, and evol

Tone
Positive 63/100
Event
Regulatory and legal
Published
09 Jul 2026 13:46
Source
Ad-hoc-news.de
AD HOC NEWS Direct company coverage

Cerus Corp updates focus on blood safety. Business model supports long-term growth

Cerus Corp (CERS) focuses on developing medical technologies to enhance blood transfusion safety, particularly through its pathogen reduction systems for platelets and plasma. The company, listed on Nasdaq, aims to reduce the risk of infection from transfused blood components for

Tone
Positive 72/100
Event
Market update
Published
08 Jul 2026 14:09
Source
AD HOC NEWS
AD HOC NEWS Direct company coverage

Cerus Corp looks to blood safety technology as investors weigh long-term growth

Cerus Corp specializes in pathogen reduction systems for blood components, enhancing transfusion safety globally. The company's business model focuses on expanding its technology and partnerships with healthcare providers and blood centers. Investors are keenly watching the long-

Tone
Positive 73/100
Event
Market update
Published
07 Jul 2026 16:39
Source
AD HOC NEWS
Finviz Direct company coverage

CERS - Cerus Corp Latest SEC Filings

This article provides comprehensive financial data and market performance metrics for Cerus Corp (CERS), highlighting its latest stock price, financial ratios, sales figures, and insider transaction details. It offers a snapshot of the company's current market position, including

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 00:39
Source
Finviz
Investing.com Direct company coverage

Cerus Corp chief legal officer Chrystal Jensen sells $71,597 in stock

Chrystal Jensen, Chief Legal Officer at Cerus Corp (NASDAQ:CERS), sold 24,329 shares of common stock totaling $71,597 on June 30, 2026. These sales were not discretionary but rather to cover tax withholding obligations and brokerage fees related to restricted stock unit vesting.

Tone
Positive 71/100
Event
Market update
Published
03 Jul 2026 23:40
Source
Investing.com
Investing.com South Africa Direct company coverage

Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes

Cerus COO Vivek Jayaraman sold $124,658 worth of company stock to cover tax withholding obligations associated with the vesting of restricted stock units. This transaction, occurring on June 30, 2026, involved the sale of 42,359 shares at an average price of $2.9429. Additionally

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 11:10
Source
Investing.com South Africa
Investing.com Direct company coverage

Cerus CFO Kevin Green sells $99,105 in CERS shares

Cerus CFO Kevin Green sold 33,676 shares of CERS stock for $99,105 on June 30, 2026, under a pre-arranged trading plan to cover tax obligations from restricted stock unit vesting, not as a discretionary sale. Following these transactions, Green directly holds 1,062,188 shares. Th

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 11:10
Source
Investing.com
Stock Titan Direct company coverage

Cerus (CERS) CFO logs tax-related share sale and new stock grant

Cerus Corp's CFO, Kevin Dennis Green, reported a non-discretionary sale of 33,676 shares at a weighted average price of $2.94 to cover tax withholding and brokerage fees related to restricted stock unit vesting. On the same date, he also received a grant of 63,600 shares at no co

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:40
Source
Stock Titan
Stock Titan Direct company coverage

Cerus (CERS) COO granted RSUs, performance rights and sells shares

Cerus Corp's COO, Vivek K. Jayaraman, received significant equity grants including 554,529 shares of common stock and 369,686 performance rights, with vesting contingent on continued service and the company's stock performance. Concurrently, he sold 42,359 shares worth approximat

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:40
Source
Stock Titan
Stock Titan Direct company coverage

Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant

Cerus Corp's Chief Legal Officer, Chrystal Jensen, reported two common stock transactions on June 30, 2026. Jensen sold 24,329 shares at a weighted average price of $2.9429 to cover tax withholding obligations and brokerage fees related to vesting restricted stock units under a R

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:40
Source
Stock Titan
Stock Titan Direct company coverage

CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant

CERUS (CERS) President and CEO William Mariner Greenman reported a tax-related sale of 101,919 shares to cover withholding and brokerage fees, alongside receiving a grant of 192,500 shares at no cost. These transactions, conducted under a Rule 10b5-1 plan, resulted in a net incre

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:09
Source
Stock Titan
TradingKey Direct company coverage

Cerus Corp (CERS) Institutional Confidence

Cerus Corp (CERS) has an institutional shareholding score of 7.00, placing it 79th out of 203 in the Healthcare Equipment & Supplies industry. Institutional investors hold 73.57% of the shares, a slight decrease of 1.81% quarter-over-quarter. Catherine Wood is the largest institu

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 17:10
Source
TradingKey
TradingKey Direct company coverage

Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis

Cerus Corp (CERS) currently holds a financial score of 8.05, placing it 48th out of 203 in the Healthcare Equipment & Supplies industry, indicating stable financial health and high operating efficiency. The company recently reported a quarterly revenue of $59.89 million, marking

Tone
Positive 74/100
Event
Earnings
Published
18 Jun 2026 05:09
Source
TradingKey
Market source Direct company coverage

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress

Cerus Corporation announced its participation in the 39th International ISBT Congress in Kuala Lumpur, Malaysia, from June 20-24, 2026. The company will host a symposium and present abstracts highlighting the INTERCEPT Blood System's role in enhancing blood safety, operational ef

Tone
Positive 70/100
Event
Market update
Published
18 Jun 2026 05:09
Source
Market source
TradingKey Direct company coverage

Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cerus Corp (CERS), detailing its current price momentum, support and resistance levels, and signals from various technical indicators and moving averages. The stock is currently trading between resistance at $3.08 and support at $2.36

Tone
Positive 65/100
Event
Market update
Published
18 Jun 2026 05:09
Source
TradingKey
TradingKey Direct company coverage

Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cerus Corp (CERS) has an earnings forecast score of 8.67, ranking 16th in the Healthcare Equipment & Supplies industry, with an average analyst price target of $5.00. Based on ratings from 3 analysts, the stock has a "Buy" trend. The expected revenue for the next quarter is $60.9

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 04:03
Source
TradingKey
TradingKey Direct company coverage

Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Cerus Corp (CERS) based on its business segments and regional contributions. For the fiscal year 2025, Product revenue accounted for 88.17% ($206.13M) and Government Contract revenue for 11.83% ($27.66M). Geographically, the

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 21:13
Source
TradingKey
TradingKey Direct company coverage

Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Cerus Corp (CERS), highlighting major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and a list of key shareholder activities with changes i

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 14:09
Source
TradingKey
TradingKey Direct company coverage

Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Cerus Corp (CERS)'s dividend and stock split history, noting that the company has distributed $0.00 in dividends over the past five years and has no recorded stock splits. It also includes current stock performance metrics such as a +8.50% gai

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 13:09
Source
TradingKey
Stock Titan Direct company coverage

Cerus takes INTERCEPT blood system data to global transfusion congress

Cerus Corporation (Nasdaq: CERS) announced its participation in the 39th International ISBT Congress in Kuala Lumpur, Malaysia, from June 20-24, 2026. The company will host a symposium and present abstracts highlighting the INTERCEPT Blood System's effectiveness in enhancing bloo

Tone
Positive 67/100
Event
Market update
Published
17 Jun 2026 12:09
Source
Stock Titan
Market source Direct company coverage

Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M

Cerus Corporation has secured a new debt facility of up to $110 million with MidCap Financial, combining a five-year term loan with an asset-backed revolving loan. This refinancing is expected to reduce annual cash interest expenses by up to $3.5 million and lowers the outstandin

Tone
Positive 74/100
Event
Balance sheet
Published
16 Jun 2026 12:39
Source
Market source